C9497 HCPCS Level II code: Loxapine, inhalation powder, 10 mg
CMS terminated C9497: its last date of service was Dec 31, 2018. It stays here for looking up older claims; newer services need a current code.
Official description
C9497Loxapine, inhalation powder, 10 mg
Short description: Loxapine, inhalation powder
HCPCS · United States
Medicare details
The indicators CMS publishes with C9497 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Other medical items or services; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Other drugs
- Coverage statute
- 1833(t)
- Cross-reference
- See J2062
- Added
- Jan 1, 2014
- Terminated after
- Dec 31, 2018
Where C9497 sits
- 1C codesOutpatient prospective payment system
- 2Terminated C9497Loxapine, inhalation powder, 10 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code C9497 still valid?
No. CMS terminated C9497; its last date of service was Dec 31, 2018. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover C9497?
CMS lists C9497’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9497
All C codesC9489Injection, nusinersen, 0.1 mgC9490Injection, bezlotoxumab, 10 mgC9491Injection, avelumab, 10 mgC9492Injection, durvalumab, 10 mgC9493Injection, edaravone, 1 mgC9494Injection, ocrelizumab, 1 mgC9507Plasma, high titer covid-19 convalescent, each unitC9600Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branchC9601Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list…C9602Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branchC9603Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery…C9604Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary…